SCHEMBL8327880

SCHEMBL8327880

CCCN(Cc1ccccc1)S(=O)(=O)c1ccc(OC)c2ncccc12

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.71
MEN1 O00255 2/20 0.71
GLA P06280 1/20 0.71
TSHR P16473 1/20 0.71
GAA P10253 2/20 0.63
ALDH1A1 P00352 7/20 0.53
HPGD P15428 3/20 0.53
KDM4E B2RXH2 2/20 0.53
HSD17B10 Q99714 2/20 0.53
PDE4A P27815 2/20 0.47
PDE4B Q07343 2/20 0.47
PDE4C Q08493 2/20 0.47
PDE4D Q08499 2/20 0.47
LMNA P02545 3/20 0.46
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.45
POLB P06746 2/20 0.43
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14919787 0.90 KMT2A (0.86) KMT2AMEN1GLATSHRGAA
SCHEMBL14919673 0.85 KMT2A (0.71) KMT2AMEN1GLATSHRGAA
SCHEMBL8327919 0.84 KMT2A (0.65) KMT2AMEN1GLATSHRGAA
SCHEMBL14919761 0.83 KMT2A (1.00) KMT2AMEN1GLATSHRGAA
SCHEMBL14919781 0.83 KMT2A (0.70) KMT2AMEN1GLATSHRGAA
SCHEMBL14919619 0.77 GAA (0.69) KMT2AMEN1GLATSHRGAA
SCHEMBL14919337 0.76 KMT2A (1.00) KMT2AMEN1GLATSHRGAA
SCHEMBL17962320 0.76 COMT (0.61) KMT2AMEN1GLATSHRKDM4E
SCHEMBL17962297 0.75 KDM4E (0.55) KMT2AMEN1GLATSHRALDH1A1
SCHEMBL7399750 0.74 ALDH1A1 (0.71) KMT2AMEN1GLATSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2193808-A1 Synergistic combination Nycomed GmbH (DE) 2010-06-09 EP disclosed
EP-1849468-A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist Nycomed GmbH (DE) 2007-10-31 EP disclosed
WO-2004047817-A1 PDE4 AND PDE3/4 INHIBITORS FOR USE IN THE TREATMENT OF CACHEXIA ALTANA PHARMA AG (DE) 2004-06-10 WO disclosed
WO-2003024488-A2 COMBINATION OF A PDE INHIBITOR AND A LEUKOTRIENE RECEPTOR ANTAGONIST ALTANA PHARMA AG (DE) 2003-03-27 WO disclosed